Another study showed that aAbs to human DNA topoisomerase I were biomarkers for favorable prognosis in breast cancer, and this antibody induced ADCC in the in vitro studies with ER+ and triple-negative human breast cancer cell lines [111]. This evidence concerns the gene ESR1 and breast cancer.